Primaxin and Intervertebral disc compression - a phase IV clinical study of FDA data

Summary:

Intervertebral disc compression is reported as a side effect among people who take Primaxin (cilastatin sodium; imipenem), especially for people who are male, 40-49 old, also take Levaquin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Intervertebral disc compression when taking Primaxin. It is created by eHealthMe based on reports of 4,534 people who have side effects when taking Primaxin from the FDA, and is updated regularly.

What is Primaxin?

Primaxin has active ingredients of cilastatin sodium; imipenem. eHealthMe is studying from 4,540 Primaxin users. Check the latest studies of Primaxin.

What is Intervertebral disc compression?

Intervertebral disc compression (spinal disc compression) is found to be associated with 285 drugs and 286 conditions by eHealthMe. Check the latest studies of Intervertebral disc compression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

4,534 people reported to have side effects when taking Primaxin.
Among them, 11 people (0.24%) have Intervertebral disc compression.

Could Primaxin cause Intervertebral disc compression?

Among these 11 people:

What is the gender of people who have Intervertebral disc compression when taking Primaxin? *

female: 0.0 %
male: 100 %

What is the age of people who have Intervertebral disc compression when taking Primaxin? *

What are other drugs people take besides Primaxin? *

What are other side effects people have besides Intervertebral disc compression? *

Weakness: 11 people, 100.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 11 people, 100.00%
Osteoporosis (bones weak and more likely to break): 11 people, 100.00%
Osteopenia (a condition where bone mineral density is lower than normal): 11 people, 100.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 11 people, 100.00%
Neuropathy Peripheral (surface nerve damage): 11 people, 100.00%
Kidney Stones: 11 people, 100.00%
Intervertebral Disc Protrusion (spinal disc protrusion): 11 people, 100.00%
Injury: 11 people, 100.00%
Infection: 11 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 45.45%
Quit Smoking: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Primaxin and have Intervertebral disc compression?

- Check whether Intervertebral disc compression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Primaxin:

Primaxin (4,540 reports)

Browse all side effects of Primaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc compression:

Intervertebral disc compression (285 drugs)

Browse all the conditions that are associated with Intervertebral disc compression:

Intervertebral disc compression (286 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cilastatin sodium; imipenem (the active ingredients of Primaxin) and Primaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.